Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | PGK1 | P00558 | 9/20 | 0.42 |
| ▸ | PGK2 | P07205 | 9/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25306698 | 0.95 | CYP2A6 (0.41) | CYP2A6PGK1PGK2ACP3ENPP2 | |
| SCHEMBL9170574 | 0.88 | PGK1 (0.50) | PGK1PGK2ACP3ENPP2 | |
| SCHEMBL9169463 | 0.82 | PGK1 (0.48) | PGK1PGK2ACP3ENPP2 | |
| SCHEMBL915502 | 0.81 | PGK1 (0.50) | CYP2A6PGK1PGK2ACP3 | |
| SCHEMBL21585529 | 0.81 | CA12 (0.44) | PGK1PGK2ACP3ENPP2 | |
| SCHEMBL29616518 | 0.81 | PGK1 (0.50) | CYP2A6PGK1PGK2ACP3 | |
| SCHEMBL1823591 | 0.80 | PGK1 (0.55) | PGK1PGK2ENPP2 | |
| SCHEMBL25411152 | 0.78 | PTPRB (0.40) | PGK1PGK2MEN1ALDH1A1MAPT | |
| SCHEMBL11043660 | 0.78 | PGK1 (0.53) | PGK1PGK2ENPP2 | |
| SCHEMBL14077361 | 0.77 | CYP2A6 (0.38) | CYP2A6KDM4EMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8872422-B2 | Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film | TSINGHUA UNIVERSITY (CN) | 2014-10-28 | — | — | US | disclosed |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | TSINGHUA UNIVERSITY (CN) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | EED, DDT, RABL6 | CYP2A6 1744/4885PGK1 4323/4885PGK2 4725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.